Skip to content

APR. BIOL. C. VANDENABEELE

Active Private limited companyfounded 2000active for 25 yearsWestkapellestraat 368, 8301 Knokke-HeistKBO/BCE: BE 0473.550.832

Lifetime

25 annual accounts with figures on one time axis
peak of €535,282 in 2022
€357,827▲ 2.2%
lowest -€17,975 in 2024
€205,078▲ €223,053
peak of €1.0m in 2025
€1.0m▲ 13.0%
€285,575▼ 4.9%
Board3 names since 2001
3 directors and 2 others
Documentsfilings and deeds
07-07-202624 days before the deadline
2025micro format
Profit of €205,078, after a lossDividend €87,620Equity from €900,662 to €1.0mInvestments €279,956Cash from €766,568 to €442,145

Key points

from the 2025 annual accounts

Equity

€1.0m ▲ 13.0%
0.92024+0.2Profit-0.09Dividend1.02025

APR. BIOL. C. VANDENABEELE paid out €87,620 in dividends. That is 43% of the 2025 profit.

Result

€205,078 €205,078
-€18,0002024€205,0002025

Back in profit in 2025, after a loss of €17,975 in 2024.

Turnover

≈ €720,000 estimated

The micro format states no turnover.

Investments

€317,927 6.5 times depreciation
20212022202320242025

Green is investment, beige is depreciation. Land and buildings stand 152.2% higher than in 2024.

Liquidity

8.90 was 12.36 in 2024

Short-term debts rose from €71,635 to €85,107.

Filings

25 annual accounts since 2001
AprilJune31 JulyOctober20102020

Four of the last ten came late. The 2018 accounts came in latest, 29 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 20,155 companies had the same profile as APR. BIOL. C. VANDENABEELE has now. Each dot stands for 51 companies, two years later.

95.0%
were still trading
4.7%
stopped another way
0.2%
went bankrupt
  • Small
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 498,062 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 20,155 companies, not a prediction for APR. BIOL. C. VANDENABEELE. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 01-01-2001
Manager, since 18-06-2007
Director, since 18-06-2007
  • deed of 18-12-2013
  • deed of 18-12-2013
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0473550832
Environmental permit granted Convert or extend · decided by Knokke-Heist
1 manager resigning, 2 directors reappointed changes role from director, formerly manager to statutory director · resigns as director, formerly manager · (statutory director) and (director) reappointed · Gazette deed
Capital decrease of €226,800 to €18,600 The capital fell from €245,400 to €18,600 · General meeting of 27-12-2017 · Gazette deed
All 47 events

Official details

Source: KBO
Status
Active since 18-12-2000Normal situation
Activity
Medical imaging and medical laboratoriesNACE 869101 activity on the establishment unitFrom the articles, 10 activities
Establishment unit
2.100.280.8209900 Eeklo, since 16-05-2001
Financial year end
31 December
Peppol
Reachable since 02-06-2025
Company details

Annual accounts 2025

€1.3m▲ 8.6%
Filing
Filed on 07-07-2026, 24 days before the end of the filing period
Financials

Insights on APR. BIOL. C. VANDENABEELE

APR. BIOL. C. VANDENABEELE files the micro format. That format states no turnover. The gross margin rose from €76,649 in 2001 to €357,827 in 2025.

The balance sheet grew most from 2021 to 2023 through fixed assets.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about APR. BIOL. C. VANDENABEELE

What is the company number of APR. BIOL. C. VANDENABEELE?
The company number of APR. BIOL. C. VANDENABEELE is 0473.550.832. The VAT number is the same number with BE in front: BE 0473.550.832.
Where is APR. BIOL. C. VANDENABEELE based?
The registered office is at Westkapellestraat 368, 8301 Knokke-Heist.Company details
What does APR. BIOL. C. VANDENABEELE do?
According to the KBO register, the main activity of the establishment unit is medical imaging and medical laboratories (NACE 86910).
What is the legal form of APR. BIOL. C. VANDENABEELE?
APR. BIOL. C. VANDENABEELE is a private limited company (BV).
When was APR. BIOL. C. VANDENABEELE founded?
APR. BIOL. C. VANDENABEELE was founded on 18-12-2000.
Is APR. BIOL. C. VANDENABEELE still active?
Yes, APR. BIOL. C. VANDENABEELE is an active enterprise in the KBO register.
What is the turnover of APR. BIOL. C. VANDENABEELE?
The turnover in financial year 2025 is about €720,000. This figure is estimated from the gross margin of €357,827 and 1,019 comparable companies of the same size. It probably lies between €500,000 and €1.0m. It is a rough estimate.Financials
Is APR. BIOL. C. VANDENABEELE profitable?
In financial year 2025, APR. BIOL. C. VANDENABEELE made a profit of €205,078.
Where can I find the annual accounts of APR. BIOL. C. VANDENABEELE?
APR. BIOL. C. VANDENABEELE filed 25 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of APR. BIOL. C. VANDENABEELE due?
APR. BIOL. C. VANDENABEELE must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.